Unverified50% confidenceFactExact time
Keytruda is a PD-1 receptor-targeting monoclonal antibody that releases T cell anti-tumor activity by blocking the binding of PD-1 to PD-L1.
1
Sources
50%
Confidence
Long-term
Relevance
9/7/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedFusobacterium nucleatum can bind to the TIGIT receptor on the surface of immune cells via the Fap2 protein, suppressing the antitumor activity of NK cells and T cells and helping tumors achieve immune evasion.62% similarUnverifiedmRNA-4157/V940 is used in combination with Merck's immune checkpoint inhibitor Keytruda (pembrolizumab).56% similarUnverified细菌触发的系统性炎症反应激活了天然杀伤细胞（NK细胞）和T细胞，从而间接清除肿瘤55% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/869772API
curl https://kongchang.com/api/v1/knowledge/claims/869772MCP
get_claim(id=869772)